Ancrod in sickle-cell crisis

Lancet. 1972 Apr 29;1(7757):934-7. doi: 10.1016/s0140-6736(72)91498-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / drug therapy*
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Bicarbonates / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Fibrin / analysis
  • Fibrinogen / analysis
  • Fibrinolysin / analysis
  • Fibrinolysis
  • Fibrinolytic Agents / therapeutic use
  • Glucose / therapeutic use
  • Humans
  • Plasminogen / analysis
  • Time Factors
  • Venoms / administration & dosage
  • Venoms / therapeutic use*

Substances

  • Anticoagulants
  • Bicarbonates
  • Fibrinolytic Agents
  • Venoms
  • Fibrin
  • Fibrinogen
  • Plasminogen
  • Fibrinolysin
  • Glucose